from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2390c/-

LFCtreatmentdescriptionclass of inhibitor

-0.030

Amikacinug/mL Amikacintranslation

-0.146

Cap5-10ug/mL Capreomycintranslation

0.238

Rox10-50 ug/mL Roxithromycintranslation

-0.331

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.209

Rif0.2-5ug/mL Rifampicintranscription

-0.075

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.975

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.857

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.150

CPZ10-50 ug/mL Chlorpromazinerespiration

0.415

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.414

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.246

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.994

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.711

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.332

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.861

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.731

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.703

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.387

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.772

KCN5-20 ug/mL Potassium cyaniderespiration

3.747

NaN30.2-2 mM Sodium aziderespiration

-0.655

Nigericin50 uM Nigericinrespiration

-0.243

TRC10-150 ug/mL Triclosanrespiration

2.277

TRZ10-25 ug/mL Thioridazinerespiration

0.112

Valinomycin0.5-10 uM Valinomycinrespiration

0.125

ZnSO42 mM ZnSO4respiration

-0.382

menadione6-10 ug/mL Menadionerespiration

-0.363

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.411

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.277

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.355

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.230

NRP_1Non-replicating persistence stage 1dosRassociated

-0.369

Amp0.2mg/mL AmpicillincellWall

-0.156

Cephalexin20-100 ug/mL CephalexincellWall

-0.849

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.455

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.551

EMB10-20 ug/mL EthambutolcellWall

-0.051

Eta12-40 ug/mL EthionamidecellWall

-0.039

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.157

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.446

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.083

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.705

BZA0.12 mg/mL BenzamidearomaticAmides

-0.247

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.013

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.592

H2O24 mM hydrogen peroxideDNAdamaging

-0.244

Levo10 ug/mL LevofloxacinDNAdamaging

-0.340

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.111

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.432

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.358

UVUV-irradiationDNAdamaging

-0.245

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.476

Antimycin12.5-50 ug/mL Antimycin A?

-0.064

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.567

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.372

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.752

PA8240.2-2 ug/mL PA-824?

-0.773

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.549

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.013

Verapamil50 uM Verapamil?

-0.314

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.242

methoxatin10-20 ug/mL Methoxatin?